| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 5 | 2022 | 1033 | 1.060 |
Why?
|
| Chemokines | 2 | 2016 | 89 | 0.970 |
Why?
|
| Butyrates | 3 | 2016 | 31 | 0.880 |
Why?
|
| Students | 2 | 2023 | 452 | 0.800 |
Why?
|
| Copper | 3 | 2012 | 101 | 0.690 |
Why?
|
| Syndecan-4 | 1 | 2018 | 4 | 0.680 |
Why?
|
| Durapatite | 1 | 2018 | 16 | 0.670 |
Why?
|
| Glutathione | 2 | 2012 | 160 | 0.650 |
Why?
|
| Minority Groups | 1 | 2023 | 537 | 0.650 |
Why?
|
| U937 Cells | 6 | 2016 | 27 | 0.630 |
Why?
|
| Histones | 1 | 2018 | 177 | 0.610 |
Why?
|
| Exosomes | 1 | 2018 | 97 | 0.600 |
Why?
|
| Tyrosine | 5 | 1999 | 109 | 0.590 |
Why?
|
| Leukemia | 2 | 2016 | 54 | 0.580 |
Why?
|
| Gene Expression | 2 | 2016 | 639 | 0.560 |
Why?
|
| Colonic Neoplasms | 4 | 2020 | 181 | 0.540 |
Why?
|
| Universities | 3 | 2023 | 363 | 0.530 |
Why?
|
| Genistein | 3 | 2005 | 41 | 0.520 |
Why?
|
| Tennessee | 3 | 2022 | 59 | 0.520 |
Why?
|
| Signal Transduction | 11 | 2022 | 1802 | 0.510 |
Why?
|
| Lipid Peroxides | 2 | 2005 | 16 | 0.500 |
Why?
|
| Nanoparticles | 1 | 2018 | 294 | 0.490 |
Why?
|
| Benzo(a)pyrene | 4 | 2020 | 122 | 0.480 |
Why?
|
| Quercetin | 2 | 2005 | 41 | 0.480 |
Why?
|
| Prostatic Neoplasms | 4 | 2023 | 794 | 0.470 |
Why?
|
| I-kappa B Kinase | 1 | 2012 | 40 | 0.440 |
Why?
|
| Humans | 30 | 2023 | 34853 | 0.440 |
Why?
|
| Nickel | 1 | 2012 | 19 | 0.440 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 109 | 0.420 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2016 | 122 | 0.420 |
Why?
|
| Lipid Peroxidation | 1 | 2012 | 131 | 0.420 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 1999 | 121 | 0.410 |
Why?
|
| Inflammation | 1 | 2016 | 577 | 0.410 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 120 | 0.410 |
Why?
|
| Colonic Pouches | 1 | 2011 | 7 | 0.400 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2011 | 18 | 0.400 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2008 | 97 | 0.390 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 200 | 0.390 |
Why?
|
| Ovarian Neoplasms | 2 | 2016 | 303 | 0.380 |
Why?
|
| Cancer Care Facilities | 1 | 2010 | 15 | 0.370 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 115 | 0.370 |
Why?
|
| Interinstitutional Relations | 1 | 2010 | 35 | 0.370 |
Why?
|
| Apoptosis | 2 | 2018 | 1317 | 0.360 |
Why?
|
| Cytokines | 2 | 2015 | 569 | 0.360 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2011 | 85 | 0.360 |
Why?
|
| Health Services Research | 1 | 2010 | 133 | 0.350 |
Why?
|
| Interleukin-17 | 2 | 1999 | 54 | 0.350 |
Why?
|
| Interleukins | 1 | 2008 | 28 | 0.330 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1997 | 40 | 0.330 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 94 | 0.320 |
Why?
|
| Schools, Medical | 1 | 2010 | 192 | 0.320 |
Why?
|
| Tumor Cells, Cultured | 7 | 2018 | 480 | 0.300 |
Why?
|
| Proto-Oncogene Proteins | 3 | 1999 | 229 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2020 | 245 | 0.290 |
Why?
|
| Phosphotyrosine | 5 | 1999 | 24 | 0.290 |
Why?
|
| Fetal Hemoglobin | 3 | 2003 | 13 | 0.270 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 413 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 1995 | 24 | 0.270 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 1300 | 0.270 |
Why?
|
| Iron | 2 | 2005 | 204 | 0.260 |
Why?
|
| Enzyme Activation | 6 | 2008 | 423 | 0.250 |
Why?
|
| Cell Line, Tumor | 4 | 2020 | 2128 | 0.250 |
Why?
|
| Flavonoids | 1 | 2005 | 78 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-raf | 3 | 1999 | 10 | 0.250 |
Why?
|
| Linolenic Acids | 1 | 2003 | 1 | 0.240 |
Why?
|
| Health Status Disparities | 1 | 2010 | 583 | 0.240 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2016 | 224 | 0.220 |
Why?
|
| United States | 2 | 2022 | 3894 | 0.220 |
Why?
|
| Cell Line | 5 | 2016 | 1289 | 0.210 |
Why?
|
| NF-kappa B | 2 | 2016 | 306 | 0.210 |
Why?
|
| Saliva | 1 | 2023 | 97 | 0.210 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2021 | 9 | 0.210 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 18 | 0.210 |
Why?
|
| Monocytes | 3 | 2008 | 258 | 0.200 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 6 | 0.190 |
Why?
|
| Research Personnel | 1 | 2022 | 133 | 0.190 |
Why?
|
| Hydroxyurea | 2 | 2003 | 34 | 0.190 |
Why?
|
| Atmospheric Pressure | 1 | 2020 | 9 | 0.190 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 132 | 0.190 |
Why?
|
| Pressure | 1 | 2020 | 36 | 0.190 |
Why?
|
| Phosphorylation | 6 | 1999 | 878 | 0.180 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 522 | 0.180 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 140 | 0.170 |
Why?
|
| Genes, jun | 2 | 1995 | 7 | 0.170 |
Why?
|
| Thiobarbiturates | 2 | 2012 | 4 | 0.170 |
Why?
|
| Ubiquitination | 2 | 2023 | 54 | 0.170 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 255 | 0.170 |
Why?
|
| Extracellular Space | 1 | 2018 | 33 | 0.170 |
Why?
|
| Trans-Activators | 1 | 1999 | 167 | 0.170 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 287 | 0.160 |
Why?
|
| Biotransformation | 1 | 2018 | 65 | 0.160 |
Why?
|
| Carcinogens | 2 | 2016 | 117 | 0.160 |
Why?
|
| Repressor Proteins | 1 | 2020 | 226 | 0.160 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 210 | 0.160 |
Why?
|
| Isoenzymes | 1 | 1998 | 149 | 0.160 |
Why?
|
| Endocytosis | 1 | 2018 | 104 | 0.160 |
Why?
|
| Protein Kinase C | 1 | 1998 | 110 | 0.160 |
Why?
|
| Hydrogen Peroxide | 2 | 2012 | 181 | 0.160 |
Why?
|
| RNA Interference | 1 | 2018 | 225 | 0.150 |
Why?
|
| Liver | 1 | 2020 | 447 | 0.150 |
Why?
|
| Ligands | 1 | 2018 | 317 | 0.150 |
Why?
|
| Interleukin-15 | 1 | 1997 | 13 | 0.150 |
Why?
|
| src-Family Kinases | 1 | 1997 | 42 | 0.150 |
Why?
|
| Chemokine CCL20 | 1 | 2016 | 7 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 781 | 0.150 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2016 | 20 | 0.150 |
Why?
|
| HL-60 Cells | 1 | 2016 | 32 | 0.140 |
Why?
|
| Valproic Acid | 1 | 2016 | 14 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2021 | 386 | 0.140 |
Why?
|
| Cell Membrane | 1 | 2018 | 360 | 0.140 |
Why?
|
| Chemokine CCL5 | 1 | 2016 | 38 | 0.140 |
Why?
|
| Cell Survival | 2 | 2016 | 818 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 93 | 0.140 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2015 | 6 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 984 | 0.140 |
Why?
|
| Genes, APC | 1 | 2015 | 14 | 0.140 |
Why?
|
| Interleukin-11 | 1 | 1995 | 3 | 0.140 |
Why?
|
| Erythroid Precursor Cells | 1 | 1995 | 6 | 0.140 |
Why?
|
| Phosphoproteins | 2 | 1995 | 154 | 0.140 |
Why?
|
| Caspase 3 | 1 | 2016 | 194 | 0.140 |
Why?
|
| Recombinant Proteins | 4 | 1999 | 485 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1995 | 74 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 146 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2015 | 116 | 0.130 |
Why?
|
| Interleukin-13 | 1 | 1995 | 18 | 0.130 |
Why?
|
| Antioxidants | 3 | 2018 | 386 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2015 | 91 | 0.130 |
Why?
|
| Mice | 6 | 2023 | 5668 | 0.130 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 2 | 2005 | 15 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 484 | 0.130 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1152 | 0.120 |
Why?
|
| Kinetics | 4 | 1998 | 650 | 0.120 |
Why?
|
| Animals | 9 | 2023 | 14307 | 0.120 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1993 | 17 | 0.120 |
Why?
|
| Blotting, Western | 4 | 1999 | 834 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2005 | 407 | 0.110 |
Why?
|
| Cell Movement | 1 | 2016 | 545 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 39 | 0.110 |
Why?
|
| Edetic Acid | 1 | 2012 | 21 | 0.110 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 2003 | 8 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 325 | 0.100 |
Why?
|
| Cell Differentiation | 4 | 2015 | 562 | 0.100 |
Why?
|
| Cell Division | 4 | 2003 | 296 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 49 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2010 | 74 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2015 | 874 | 0.090 |
Why?
|
| Research Support as Topic | 1 | 2010 | 75 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 166 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2010 | 110 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2011 | 231 | 0.090 |
Why?
|
| Risk Factors | 2 | 2023 | 3414 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2023 | 897 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1149 | 0.090 |
Why?
|
| Butadienes | 1 | 2008 | 30 | 0.080 |
Why?
|
| Nitriles | 1 | 2008 | 66 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 205 | 0.080 |
Why?
|
| Incidence | 1 | 2011 | 882 | 0.080 |
Why?
|
| Butyric Acid | 2 | 1998 | 17 | 0.080 |
Why?
|
| Male | 6 | 2023 | 18870 | 0.080 |
Why?
|
| Disease Progression | 2 | 2021 | 580 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2000 | 396 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2008 | 490 | 0.070 |
Why?
|
| Genes, fos | 2 | 1995 | 14 | 0.070 |
Why?
|
| Transfection | 2 | 2016 | 496 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 171 | 0.060 |
Why?
|
| K562 Cells | 2 | 2003 | 31 | 0.060 |
Why?
|
| Time Factors | 2 | 1999 | 1681 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2023 | 3 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2023 | 42 | 0.060 |
Why?
|
| Ferrous Compounds | 1 | 2003 | 20 | 0.060 |
Why?
|
| Monosaccharides | 1 | 2003 | 9 | 0.060 |
Why?
|
| Ions | 1 | 2003 | 61 | 0.060 |
Why?
|
| Drug Stability | 1 | 2003 | 110 | 0.060 |
Why?
|
| Urea | 1 | 2003 | 42 | 0.060 |
Why?
|
| Lysosomes | 1 | 2023 | 80 | 0.060 |
Why?
|
| Female | 3 | 2023 | 19873 | 0.050 |
Why?
|
| alpha-Fetoproteins | 1 | 2022 | 29 | 0.050 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2021 | 8 | 0.050 |
Why?
|
| Benzamidines | 1 | 2000 | 4 | 0.050 |
Why?
|
| Hemoglobin, Sickle | 1 | 2000 | 13 | 0.050 |
Why?
|
| Porosity | 1 | 2020 | 32 | 0.050 |
Why?
|
| Streptozocin | 1 | 2000 | 21 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2000 | 30 | 0.050 |
Why?
|
| Solvents | 1 | 2020 | 93 | 0.050 |
Why?
|
| STAT2 Transcription Factor | 1 | 1999 | 1 | 0.050 |
Why?
|
| TYK2 Kinase | 1 | 1999 | 2 | 0.050 |
Why?
|
| STAT4 Transcription Factor | 1 | 1999 | 3 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2020 | 162 | 0.050 |
Why?
|
| Receptors, Interleukin-17 | 1 | 1999 | 8 | 0.050 |
Why?
|
| Fluorescence | 1 | 2020 | 117 | 0.050 |
Why?
|
| Receptors, Interleukin | 1 | 1999 | 10 | 0.050 |
Why?
|
| Janus Kinase 1 | 1 | 1999 | 17 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 1999 | 51 | 0.050 |
Why?
|
| Janus Kinase 3 | 1 | 1999 | 33 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 1999 | 31 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 1999 | 26 | 0.040 |
Why?
|
| Protein Kinase C-epsilon | 1 | 1998 | 14 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 1999 | 80 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1998 | 48 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 1999 | 86 | 0.040 |
Why?
|
| DNA Adducts | 1 | 2018 | 41 | 0.040 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2018 | 43 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1425 | 0.040 |
Why?
|
| Carcinogens, Environmental | 1 | 2018 | 34 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2018 | 83 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2018 | 197 | 0.040 |
Why?
|
| Water | 1 | 2020 | 283 | 0.040 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1997 | 9 | 0.040 |
Why?
|
| Peritoneal Cavity | 1 | 2016 | 6 | 0.040 |
Why?
|
| Chemokine CXCL1 | 1 | 2016 | 15 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 87 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 1997 | 87 | 0.040 |
Why?
|
| Proteins | 1 | 1999 | 352 | 0.040 |
Why?
|
| Rats, Mutant Strains | 1 | 2016 | 5 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2016 | 132 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 1996 | 186 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fes | 1 | 1995 | 3 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 323 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 142 | 0.030 |
Why?
|
| Isoflavones | 1 | 1996 | 125 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2561 | 0.030 |
Why?
|
| Hydroquinones | 1 | 1995 | 8 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 195 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 195 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1993 | 13 | 0.030 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1993 | 18 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1993 | 38 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1993 | 161 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 1993 | 203 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 1995 | 968 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 1993 | 1442 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 3261 | 0.020 |
Why?
|
| Ribonucleotide Reductases | 1 | 2000 | 6 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 217 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2000 | 756 | 0.010 |
Why?
|